Correlation analysis showed a negative relationship between serum syndecan-1 levels and cIMT, while regression analysis suggested that lower syndecan-1 levels in patients with Behçet’s disease might be associated with subclinical atherosclerosis. Here, SDC1 is linked to atherosclerosis.